Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

News Conference News EAS 2023

Newest Resorbable Magnesium Scaffold Shows Promise in BIOMAG-1

Michael O'Riordan

May 25, 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

March 04, 2023

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

News Features

Year in Review: ISCHEMIA Tops Coronary News in 2019 but Other Trials Shine, Too

Michael O'Riordan

December 09, 2019

Plaque Characteristics on OCT Offer Clues About Atherosclerotic Causes of MINOCA

News Daily News

Plaque Characteristics on OCT Offer Clues About Atherosclerotic Causes of MINOCA

October 23, 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

SCAI Updates Statement on Intracoronary Diagnostic Tools

News Daily News

SCAI Updates Statement on Intracoronary Diagnostic Tools

July 17, 2018

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

News Daily News

ILUMIEN I Published: OCT Can Affect PCI Strategy

August 17, 2015

News Industry News

St. Jude Medical Announces Launch of the First International Trial to Compare OCT-Guided Stent Implantation to IVUS or Angiography-Guided PCI

June 30, 2015

News Daily News

Small OCT Study Suggests Favorable Long-term Response to Bioresorbable Scaffold

December 04, 2014

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.